McCourt Marion — SEC Form 4 filings
SEC reporting owner CIK 1663758. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-02 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 12 filings — 10,889 shares, $10,594,804 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 1,137 shares @ $1,060.86 ($1,206,198) in REGENERON PHARMACEUTICALS, INC., filed 2024-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP Commercial | 16 | — | 13 legs · 10,889 sh · $10,594,804 | 20 |
Form 4 filings — McCourt Marion
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,215 @ $850 · Sale (S): 1,131 @ $857.39 | EDGAR |
| 2025-12-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 1,021 @ $701.51 | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,476 @ $0 · Tax withholding (F): 1,336 @ $712.94 · Grant/award (A): 12,210 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 759 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,332 @ $0 · Tax withholding (F): 274 @ $787 · Grant/award (A): 8,981 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $381.40 · Sale (S): 1,000 @ $844.61 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $381.40 · Sale (S): 1,000 @ $1,054.06 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $381.40 · Sale (S): 1,000 @ $1,178.73 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,137 @ $372.46 · Sale (S): 1,137 @ $1,060.86 · Option exercise (M): 1,137 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,137 @ $372.46 · Sale (S): 1,137 @ $1,047.11 · Option exercise (M): 1,137 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,138 @ $372.46 · Sale (S): 1,138 @ $980.16 · Option exercise (M): 1,138 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $889.41 | EDGAR |
| 2024-04-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $964.73 | EDGAR |
| 2024-03-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 358 @ $967.50 | EDGAR |
| 2024-02-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $934.71 | EDGAR |
| 2024-02-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 273 @ $945.61 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1663758 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →